2018 Scientific Sessions

CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia

Kiran Musunuru, MD presents his talk on CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia at the 2018 Scientific Sessions in Las Vegas, Nevada.

Expert Debate on CVD Risk Reduction in the Cardiometabolic Patient

Resistant Hypertension: A Practical Approach to the Guidelines

Michael Bloch, MD presents his talk on Resistant Hypertension at the 2018 Scientific Sessions in Las Vegas, Nevada.

Update on Clinical Trials: How Will This Affect Practice in the Future?

Pamela Morris, MD presents her update on clinical trials at the 2018 Scientific Sessions in Las Vegas, Nevada.